UMC Amsterdam University
COUNTER-COVID - Oral imatinib to prevent pulmonary vascular leak in COVID-19 – a randomized, single-blind, placebo controlled, clinical trial in patients with severe COVID-19 disease.
Technology:
Research and Academia
Industry:
COVID
Headquarters:
Netherlands
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership